Meeting
2014 Gastrointestinal Cancers Symposium
Identifying BRAF mutations in colorectal cancer (CRC) by initial immunohistochemical (IHC) staining for mismatched protein expression as part of a Lynch syndrome screening program: A distinct clinicopathologic entity.
Authors
Thomas H. Grote
Novant Health D. L. Davis Cancer Center, Winston-Salem, NC
Thomas H. Grote , Scott E. Kilpatrick , Dena B. Webb , Amy Herndon Hughes , Sarah Hughes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 405)
DOI
10.1200/jco.2014.32.3_suppl.405
Abstract #
405
Poster Bd #
A24
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Evaluating the clinical utility of universal screening to identify Lynch syndrome in stage III/III colorectal cancer patients: A prospective observational study in Japan.
First Author: Yasuaki Yamamoto
Poster
2019 Gastrointestinal Cancers Symposium
Streamlining universal screening for lynch syndrome (LS): Towards improved yield of genetic counseling (GC).
First Author: Stefania Sciallero
Poster
2018 Gastrointestinal Cancers Symposium
First results of universal screening for Lynch syndrome in a Mexican cohort of colorectal cancer patients.
First Author: Zuleyma Nieto
Poster
2018 ASCO Annual Meeting
Long-term (7-year) outcomes of universal mismatch repair screening (uMMR) of 1156 colorectal (CRC) and endometrial cancers (EC) in an academic setting.
First Author: Michael J. Hall